On Tuesday, Jan. 10, Global Healthcare will become Reuters Health Rounds, a newsletter curated by Nancy Lapid, editor in charge of Reuters Health. Reuters Health Rounds will be sent on Tuesdays and Thursdays.
India's Hetero said on Tuesday that its generic version of Paxlovid, an antiviral treatment for COVID-19 developed by Pfizer Inc , was added to the World Health Organization's prequalification list, which serves as a benchmark for procurement of medicines by developing countries.
The U.S. Food and Drug Administration (FDA) is planning to make recommendations on how to regulate the use of popular cannabis compound CBD in food and supplements, the Wall Street Journal reported on Tuesday, citing agency officials.
Chinese people, cut off from the rest of the world for three years by stringent COVID-19 curbs, flocked to travel sites on Tuesday ahead of borders reopening next month, even as rising infections strained the health system and roiled the economy.
Niger has reported the highly contagious H5N1 strain of avian influenza, or bird flu, among poultry in a village in the south of the country, the Paris-based World Organisation for Animal Health (WOAH) said on Tuesday.
India's pharmaceuticals regulator has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
China's relaxation of COVID-19 rules for international arrivals has raised hopes that its multi-billion dollar travel business will soon flourish again but countries longing for the return of Chinese tourists will likely face more of a wait.
Hungarian drugmaker Richter expects to pay about 28 billion forints ($74.44 million) worth of extra taxes this year, it said on Tuesday, hit by tax hikes on big businesses to plug budget holes.
China's Shanghai Fosun Pharmaceutical Group said users of its mobile health app in China can now register to take COVID-19 booster shots in Hong Kong using BioNTech's vaccine.
China will eventually publish data on COVID-19 cases once a month when the disease comes under Category B management, an official at the Chinese Center for Disease Control and Prevention said on Tuesday.
China reported one new COVID-19 death in mainland for Dec. 26, compared with no deaths a day earlier, the Chinese Center for Disease Control and Prevention said on Tuesday.
